興科蓉醫藥：年報2019.pdf

1、(Incorporated under the laws of the Cayman Islands with limited liability)(根據開曼群島法例註冊成立的有限公司)Stock Code 股份代號:6833(Incorporated under the laws of the Cayman Islands with limited liability)(根據開曼群島法例註冊成立的有限公司)Stock Code 股份代號:68332019 年報ANNUAL REPORT Contents目錄2Corporate Information公司資料4Financial Highli

2、ghts財務摘要6Chairman s Statement主席報告9Management Discussion and Analysis管理層討論及分析26Environmental,Social and Governance Report環境、社會及管治報告48Directors and Senior Managements董事及高級管理層54Report of the Directors董事會報告71Corporate Governance Report企業管治報告94Independent Auditor s Report獨立核數師報告101Consolidated Statement

3、of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表102Consolidated Statement of Financial Position綜合財務狀況表104Consolidated Statement of Changes in Equity綜合權益變動表105Consolidated Statement of Cash Flows綜合現金流量表108Notes to Financial Statements財務報表附註218Definitions釋義2Sinco Pharmaceuticals Holdings L

4、imited Annual Report 2019Corporate Information公司資料BOARD OF DIRECTORSExecutive DirectorsMr.Huang Xiangbin(Chairman and Chief Executive Officer)Ms.Zhang ZhijieIndependent Non-executive DirectorsMr.Lau Ying KitMr.Wang QingMr.Liu WenfangAUDIT COMMITTEEMr.Lau Ying Kit(Chairman)Mr.Liu WenfangMr.Wang QingR

5、EMUNERATION COMMITTEEMr.Wang Qing(Chairman)Ms.Zhang ZhijieMr.Liu WenfangNOMINATION COMMITTEEMr.Huang Xiangbin(Chairman)Mr.Liu WenfangMr.Lau Ying KitINTERNAL CONTROL AND CORPORATE GOVERNANCE COMMITTEEMr.Lau Ying Kit(Chairman)Mr.Wang QingMr.Liu WenfangAUTHORISED REPRESENTATIVESMr.Huang XiangbinMs.Ko W

6、ing Yu(appointed on 29 March 2019 and resigned on 25 October 2019)Ms.Li Ching Yi(appointed on 25 October 2019)Ms.Leung Suet Lun(resigned on 29 March 2019)JOINT COMPANY SECRETARIESMs.Peng Yunlu(appointed on 25 October 2019)Ms.Li Ching Yi(appointed on 25 October 2019)Ms.Ko Wing Yu(resigned on 25 Octob